Related Experiment Video
Updated: May 28, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein
Jing Zhang1, Bifeng Yuan, Fan Zhang
1Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an 710062, P. R. China.
Abstract:
Aberrant cytosine methylation is known to be associated with cancer development. Here, we assessed how common cancer chemotherapeutic agents perturb cytosine methylation in Jurkat-T acute lymphoblastic leukemia cells. We tested six antitumor agents and found that cyclophosphamide induced the most pronounced increase in global DNA cytosine methylation after a 24-h treatment. Long-term treatment with cyclophosphamide led to a time-dependent increase in cytosine methylation level with up to 4 days of treatment, and the extent of cytosine methylation returned to normal level after 8 days. The trend of change in DNA methylation level paralleled that of the expression level of DNMT1 protein, whereas no significant increase in DNMT1 mRNA level was observed. Previous studies showed that the stability of endogenous DNMT1 protein is regulated by lysine methylation through histone lysine methyltransferase Set7 and lysine-specific demethylase 1 (LSD1), with the methylated DNMT1 being the target for proteasomal degradation. We observed that the elevated expression of DNMT1 protein at 4 days of treatment was correlated with the increased expression of LSD1 protein and with the decreased frequency of K142 methylation in DNMT1. Taken together, our results showed that cyclophosphamide perturbed temporarily global cytosine methylation in Jurkat-T cells via regulation of the lysine methylation level in DNMT1.
Insights
Cyclophosphamide temporarily increases global DNA cytosine methylation in leukemia cells by affecting DNMT1 protein stability. This epigenetic alteration in cancer cells returns to normal levels after 8 days.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Pharmacology
Background:
- Aberrant DNA cytosine methylation is a hallmark of cancer development.
- Chemotherapeutic agents can influence epigenetic modifications, impacting cancer progression.
- Understanding these drug-induced epigenetic changes is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the effects of common chemotherapeutic agents on DNA cytosine methylation in Jurkat-T acute lymphoblastic leukemia cells.
- To identify which agents cause the most significant perturbations in global DNA methylation.
- To elucidate the molecular mechanisms underlying drug-induced methylation changes.
Main Methods:
- Treatment of Jurkat-T cells with six different antitumor agents.
- Assessment of global DNA cytosine methylation levels over time.
- Analysis of DNA methyltransferase 1 (DNMT1) protein and mRNA expression.
- Investigation of DNMT1 protein stability regulation by lysine methylation and associated enzymes like LSD1.
Main Results:
- Cyclophosphamide induced the most significant increase in global DNA cytosine methylation after 24 hours.
- Long-term cyclophosphamide treatment showed a time-dependent increase in methylation, returning to normal by day 8.
- Increased DNMT1 protein levels correlated with increased LSD1 protein and decreased DNMT1 K142 methylation.
- DNMT1 mRNA levels did not significantly increase, suggesting post-transcriptional regulation.
Conclusions:
- Cyclophosphamide temporarily alters global DNA cytosine methylation in leukemia cells.
- The observed changes are mediated by the regulation of DNMT1 protein stability through lysine methylation.
- These findings highlight a novel mechanism by which chemotherapy impacts epigenetic regulation in cancer cells.
More Related Videos
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
Inhibition of Cdk Activity
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
DNA Damage can Stall the Cell Cycle